Huei Wang

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi, Michael A. Carducci, Matthew R. Smith et al. · The Lancet · 2011 · 2K citations · Full text

Medicine, Oncology, Urology +17

Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

Jacques P. Brown, Richard L. Prince, Chad Deal et al. · Journal of Bone and Mineral Research · 2008 · 604 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer et al. · New England Journal of Medicine · 2022 · 521 citations · Full text

Life Sciences, Cardiology, Molecular Biology +14

Cognitive Function in a Randomized Trial of Evolocumab

Robert P. Giugliano, François Mach, Kenton H. Zavitz et al. · New England Journal of Medicine · 2017 · 482 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

Stephen J. Nicholls, Yu Kataoka, Steven E. Nissen et al. · JACC. Cardiovascular imaging · 2022 · 429 citations

Medicine, Cardiology, Pharmacotherapy +16